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Objective: Older people with reduced respiratory muscle strength may be misclassified 
as having COPD on the basis of spirometric results. We aimed to evaluate the relation-
ship between lung function and grip strength in older hospitalized patients without known 
airways disease.
Methods: Patients in acute medical wards were recruited who were aged $70 years; no history, 
symptoms, or signs of respiratory disease; Mini Mental State Examination $24; willing and able 
to consent to participate; and able to perform hand grip and forced spirometry. Data including 
lung function (forced expiratory volume in 1 second [FEV
1
], forced vital capacity [FVC], FEV
1
/
FVC, peak expiratory flow rate [PEFR], and slow vital capacity [SVC]), grip strength, age, 
weight, and height were recorded. Data were analyzed using descriptive statistics and linear 
regression unadjusted and adjusted (for age, height, and weight).
Results: A total of 50 patients (20 men) were recruited. Stronger grip strength in men was 
significantly associated with greater FEV
1
, but this was attenuated by adjustment for age, height, 
and weight. Significant positive associations were found in women between grip strength and 
both PEFR and SVC, both of which remained robust to adjustment.
Conclusion: The association between grip strength and PEFR and SVC may reflect stronger 
patients generating higher intrathoracic pressure at the start of spirometry and pushing harder 
against thoracic cage recoil at end-expiration. Conversely, patients with weaker grip strength 
had lower PEFR and SVC. These patients may be misclassified as having COPD on the basis 
of spirometric results.
Keywords: older, grip strength, spirometry, peak expiratory flow rate, slow vital capacity
Introduction
There is concern that older people with reduced respiratory muscle strength may 
be misclassified as having COPD on the basis of spirometric results and receive 
unnecessary and potentially harmful treatment. With increasing age, the smaller 
pulmonary airways more readily collapse and forced vital capacity (FVC), forced 
expiratory volume in 1 second (FEV
1
), and forced expiratory flow decrease; there is 
an increase in functional residual capacity and expiratory reserve volume, residual 
volume increases, and there is little change in total lung capacity.1–3 In addition with 
aging, there is a decreased respiratory response to hypoxemia and hypercapnia and a 
reduced perception of raised resistance of the airway.2 There is a loss of synovial joints 
between the sternum and the costal cartilages reducing chest wall compliance and 
tension forces, leading to reduced maximal respiratory pressure and decreased muscle 
mass and strength of accessory respiratory muscles.4 It has also been observed that 
there is a significant decrease by 25% in the diaphragm strength in the older compared 
with young adults.5 One study has observed that inspiratory (mainly diaphragmatic) 
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strength has been considered to be the most relevant in rela-
tion to function, fatigue, and training.6
With aging, there is a triad of loss of muscle mass, 
strength, and function defined as sarcopenia. This is common 
and has serious consequences including increased risk 
of current and future falls, dependency, hospitalization, 
and mortality. Grip strength is recommended as a simple 
standardized clinical measure used in the diagnosis of 
sarcopenia.7 Age-associated skeletal muscle changes may 
impact respiratory muscle function, and a positive correla-
tion between grip strength and inspiratory and expiratory 
muscle strength has been demonstrated.8–10 Reduced lung 
function (in particular FEV
1
 and FVC) after adjusting for 
age, smoking, and physical activity has been demonstrated 
with reduced skeletal muscle mass in Korea.11
COPD is defined by the Global initiative for chronic 
Obstructive Lung Disease (GOLD) by symptoms, exposure 
to risk factors (namely smoking), family history, and con-
firmation with spirometry with a postbronchodilator FEV
1
/
FVC ,0.70 and postbronchodilator FEV
1
 (to assess degree 
of airflow limitation).12
Discord over the standardized definition of COPD across 
international groups (whether a fixed ratio, use of standard-
ized age-related reference spirometry ranges, or lower limit 
than normal spirometry values) makes it difficult to compare 
the prevalence of COPD across populations and across 
studies due to the lack of standardized protocol.13 FEV
1
/FVC 
ratio decreases with aging and is included in the GOLD 
definition of COPD using the criteria of postbronchodilator 
FEV
1
/FVC ,0.70. There is a decrease in FEV
1
 with aging 
likely to be due to age-related airway compliance changes and 
this is incorporated in the GOLD definition to assess the sever-
ity of airflow limitation. Both criteria have potential to lead to 
increasing diagnosis of COPD in older nonsmoking patients 
with no lung pathology.14 Normal reference spirometry values 
have been defined in older age groups; however, these are not 
included in the international definition of COPD.15,16
Peak expiratory flow rate (PEFR) in older adults is an 
inexpensive measure, assessed alongside other respira-
tory function and used in previous studies evaluating grip 
strength, respiratory muscle strength, and lung function.17 
It measures maximal expiratory flow, is effort dependent, and 
represents airflow through larger caliber airways.18 PEFR has 
been used to assess adherence and benefit of treatments for 
airways disease and one of its limitation is the variability in 
performance in older persons. Older age, reduced body size, 
smoking, cardiovascular, respiratory, and cognitive diseases 
are associated with a reduced PEFR.17,19
Slow vital capacity (SVC) may be easier for some older 
adults who have difficulty coordinating the more FVC due 
to factors, such as reduced cognitive ability, coughing dur-
ing the maneuver, weakness, or fatiguability.20 Again SVC 
is an inexpensive measure that can be tested alongside other 
respiratory measures using the same spirometry equipment. 
However, it is not incorporated in the international definitions 
of airways obstruction. It is also recognized that some older 
adults with cognitive impairment may be unable to perform 
both SVC and FVC.20
There is increasing interest in the relationship between 
sarcopenia, respiratory muscle strength, and lung function 
in patients with COPD.21–23 However, there has been very 
limited evaluation of sarcopenia, respiratory muscle strength, 
and lung function in older people without known airways 
disease. This study aimed to evaluate the relationship of grip 
strength and lung function in older hospital patients without 
known respiratory disease.
There is an increasing recognition of an association 
between muscle strength and lung function in people with 
COPD. It is unknown whether there is a relationship between 
grip strength and lung function in older non-smoking adults. 
In this study, older non-smoking patients with weaker grip 
strength had lower PEFR and SVC. Reduced spirometric 
lung function measurements in weaker older individuals may 
contribute to misdiagnosis of COPD.
Materials and methods
study design and ethics
This was a prospective study on patients aged $70 years 
admitted to acute older people’s wards at a university hospital 
in the UK over a 6-month period. Southampton and South 
West Hampshire Research Ethics Committee gave approval 
for this study, which was registered with ClinicalTrials.gov 
(NCTO1647204).
Participants
The inclusion criteria for recruitment were age .70 years, a 
history of never smoking or trivial smoking ,1 year, no history, 
symptoms or signs of respiratory disease, and negative for bron-
chial obstruction on the respiratory symptom questionnaire.24
Exclusion criteria were met if any participant was unable 
to meet all of the inclusion criteria, had a Mini Mental 
State Examination (MMSE) score of ,24, or had any 
contraindication to performing spirometry according to the 
Association for Respiratory Technology and Physiology 
(ARTP) guidelines.25 These contraindications included 
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relationship between lung function and grip strength in older patients
infarction in the last one month; pulmonary embolism; tho-
racic, abdominal, or cerebral aneurysms; recent eye surgery; 
nausea or vomiting; and recent thoracic or abdominal surgery. 
In addition, if participants appeared nonspecifically unwell 
or nursing staff had concerns about participation, then they 
were not approached.
A convenience sample of eligible patients (based on the 
researcher’s availability) were approached for recruitment, 
then given a patient information sheet and opportunity to 
ask further questions before written informed consent was 
obtained. Each participant was taken through the brief 
respiratory questionnaire to ensure they had no symptoms 
that would affect carrying out the spirometry or exclude them 
from the study: any positive response to the questionnaire 
excluded recruitment to the study. Participants were also 
asked about any contraindication to performing spirometry 
according to the ARTP guidelines, and this was confirmed 
on review of case notes before performing spirometry with 
the participants’ permission.
Data collection
Participants’ height was calculated from ulna length 
measurement,26 as the majority of participants were unable 
to stand. Weight was measured using sitting scales at the 
bedside. Body mass index was calculated by dividing body 
weight by the square of height (kg/m2). Cognitive function 
was assessed using the MMSE,27 which has been an estab-
lished screening tool in spirometry studies in older people.
A calibrated Jamar dynamometer was used to measure 
grip strength using a standard protocol. Three measurements 
were recorded for each hand to the nearest 1 kg and the 
maximum grip recorded.28 A Microlab Portable spirometer 
was used to measure FEV
1
, FVC, PEFR (best of five mea-
surements recorded), and SVC (best of three measurements 
recorded). The spirometer was calibrated for each assess-
ment. Measurements were recorded in the sitting position, 
feet on the floor, spine erect, and without support for the upper 
limbs. Repeatability was considered to be adequate when 
there was a difference of #0.15 L between the maximum 
and the next largest FVC and between the maximum and 
next largest FEV
1
. In patients with FVC #1 L, a difference 
of #0.10 L was used. SVC attempts were considered to be 
acceptable if the individual breathed in to total lung capacity 
then breathed out until flow had ended for at least 1 second. 
SVC measurements were considered to be repeatable if the 
two highest attempts varied by #0.2 L. The highest record-
ing was taken for each measurement. However, to assure the 
quality of these data, two observers reviewed spirograms of 
each patient separately and together to see if they reflected 
adequate performance.29
statistical analysis
Data were entered into a database and analyzed using IBM 
SPSS Statistics 20 software separately for men and women. 
Normality of variables was assessed using visual inspection 
of histograms and skewness. Mean and standard deviation, 
median and interquartile ranges were used to describe the 
participants’ demographic and clinical characteristics, grip 
strength, and spirometry results. Comparison between men and 
women was conducted using independent sample t-tests and the 
Mann–Whitney U-test accordingly. The association between 
lung function variables and grip strength were assessed for men 
and women separately using linear regression analysis both 
unadjusted and adjusted for age, height, and weight.
Results
A total of 601 patients were screened over 6 months of which 
509 were excluded: 58 patients with acute respiratory illness, 
48 with known respiratory disease, 109 patients with more 
than 1 year of smoking history, 13 with acute illness, and 
281 with known moderate or severe cognitive impairment. 
The 92 eligible patients were approached with information 
leaflets and of these 50 (54%) consented to take part in the 
study (Figure 1).
Patient characteristics are recorded in Table 1. Spirometry 
was difficult to achieve reproducibility of the results and for 
patients to rehearse the technique without becoming fatigued, 
to ensure effort in the early part of forced expiration, and 
to avoid patients stopping mid-expiration. After review of 
10 patients, SVC was introduced for the remaining 40 patients. 
SVC can be easier and more relaxed than FVC, and can avoid 
coughing triggered by the forced maneuver.20
The association of lung function with grip strength is 
shown in Table 2. There was a wide variation in participants’ 
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PEFR values. In men, grip strength was significantly asso-
ciated with FEV
1
 but this was attenuated by adjustment for 
age, height, and weight. Significant associations were found 
in women between grip strength and PEFR and between 
grip strength and SVC, both of which remained robust to 
adjustment. No other significant relationship was found.
Discussion
Grip strength was significantly stronger, and lung function 
was significantly larger in men compared with women prob-
ably due to their larger body size allowing them to generate 
greater intrathoracic pressures and higher lung volumes. 
Stronger grip strength was significantly associated with a 
larger FEV
1
 in men, but the significance was attenuated after 
adjustment for age, height, and weight.
No significant relationship was found between grip 
strength and FEV
1
 in women. In line with previous reports, 
this study demonstrated variation in PEFR values among the 
participants.17–19 Reduced PEFR was demonstrated in women 
with low grip strength. Low FEV
1
 and low PEFR in weaker 
individuals could be due to increased parenchymal compli-
ance. PEFR may be a useful measure of airflow obstruction, 
and change in response to treatment may be less reliable in 
older women with low grip strength.
Increased grip strength was associated with a larger FVC 
in both men and women but was not statistically significant. 
There was no significant association between grip strength 
and ratio of FEV
1
/FVC. This result reflected patients with a 
similar reduction in both FEV
1
 and FVC and a lack of con-
sistency in spirometry. Importantly, SVC appeared to be a 
more practical and applicable lung function measure in this 
older patient group than FVC.
Stronger grip strength was significantly associated with 
larger PEFR and SVC in women but not in men. PEFR and 
SVC may be more significant in women in this study reflect-
ing stronger patients generating higher intrathoracic pressure 
at the start of spirometry and pushing harder against thoracic 
cage recoil at end-expiration. Differences found between 
women and men may be related to smaller airways and lung 
volumes in women compared with men.
A relationship between grip strength and FEV
1
 in patients 
who were healthy subjects and with COPD was inferred in a 
recent study in India. This study demonstrated that a decrease 
in grip strength was associated with a decrease in FEV
1
 in 
women and in FVC in men; however, it did not adjust for 
age or body size.30 Current studies that report FEV
1
/FVC 
do so only in the context of patients with lung pathology, 
smokers, or a mixed group and do not compare this to grip 
strength or adjust for body size.31 One study showed a 
significant correlation between grip strength and PEFR in 
hospital staff but again did not adjust for age and height.17 
A further limitation of current research in the relationship 
between grip strength and lung function is a lack of standard-
ization of instruments used and methodology particularly in 
assessing older subjects. There is also a lack of consensus 
Table 1 Participant characteristics and their grip strength and 
spirometry





age, yearsa (n=50) 86.3 (4.9) 87.5 (4.8) 0.44
height, ma (n=50) 1.71 (0.7) 1.60 (0.7) 0.81
Weight, kga (n=50) 74.9 (15.1) 66.0 (16.4) 0.64
BMI, kg/m2a (n=50) 25.6 (5.3) 26.0 (6.4) 0.36
MMseb (n=50) 26 (24,28) 27 (25,29) 0.04
grip strength, kga (n=50) 19.5 (7.21) 12.4 (3.73) 0.03
FeV1, l/s
c (n=50) 1.7 (0.5) 1.0 (0.3) 0.02
FVC, lc (n=50) 2.1 (0.7) 1.4 (0.4) 0.01
FeV1/FVC, %
c (n=50) 77.6 (14.3) 73.6 (12.2) 0.88
PeFr, lc (n=50) 262.1 (102.5) 148.1 (57.5) 0.004
sVC, lc (n=40) 2.1 (0.9) 1.2 (0.4) 0.003
Notes: aMean (sD); bmedian (IQr); cmean (sD) using t-test. P-values were calculated 
using student’s t-test.
Abbreviations: BMI, body mass index; FeV1, forced expiratory volume in 
1 second; FVC, forced vital capacity; MMse, Mini Mental state examination; PeFr, 
peak expiratory flow rate; SVC, slow vital capacity; SD, standard deviation; IQR, 
interquartile range.
Table 2 association of grip strength and lung function in the older participants
Lung function Men Women
Unadjusted Adjusteda Unadjusted Adjusteda
β P β P β P β P
FeV1 (l/s) 0.03 0.05 0.04 0.06 0.02 0.24 0.02 0.27
FVC (l) 0.04 0.07 0.06 0.07 0.02 0.33 0.02 0.35
FeV1/FVC (%) 0.08 0.87 −0.14 0.85 0.17 0.79 0.17 0.79
PeFr (l) 4.61 0.16 6.60 0.15 6.88 0.01 6.94 0.02
sVC (l) 0.03 0.25 0.04 0.34 0.05 0.03 0.05 0.05
Note: aadjusted results for age, height, and weight.
Abbreviations: β, Beta coefficient; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; PEFR, peak expiratory flow rate; P, probability value calculated 
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relationship between lung function and grip strength in older patients
on appropriate spirometry measures and protocols within 
research and agreement as to defined spirometry measures 
in clinical practice for diagnosing COPD.
There were limitations to the study. The sample 
size was small and patients with cognitive impairment, 
smokers .1 year, or acutely ill were excluded. The 
significance of this study’s findings has to be taken within 
this context and are preliminary findings. Recruiting partici-
pants based on the researcher’s availability may have led to 
potential eligible patients not being included but would not 
have resulted in observer bias.
This study examined individuals far older than in previous 
studies and this older group had difficulty maintaining the 
consistency to conform to the American Thoracic Society 
(ATS) guidelines for spirometry. We reported the maximum 
spirometry values rather than the mean values recognizing 
that with repeated testing some patients may fatigue. This 
could be standardized by setting limits to exclude lung func-
tion tests, for example, with FEV
1
/FVC .90% or ,60% 
and abnormal spirogram patterns. Assessment of SVC in all 
participants would have been beneficial; however, this was 
not possible to obtain due to participants being discharged 
home. Further evaluation of SVC to measure airway obstruc-
tion particularly with those limited by coughing may be useful 
as a research tool and in practice.
There were also several strengths to this study. We per-
formed it with a single researcher with trained competency 
in collecting data confirmed with intraobserver variability 
assessment. The study was carried out using calibrated 
instruments. The use of a standardized method for measuring 
grip strength was advantageous and is not usually the case 
in other studies in older persons. Similarly, we performed 
spirometry in a standardized way that would allow easy 
comparison to other studies.
We considered the appropriateness of performing 
spirometry in hospitalized patients given the potential 
instability of this population. Previous studies have high-
lighted variability in spirometry results particularly in older 
participants with cognitive impairment (due to an inability 
to coordinate or perform the test in a standardized manner), 
those acutely ill, and smokers (secondary to pathophysi-
ologic changes).20 Therefore, we decided to use rigorous 
exclusion criteria to standardize recruitment and enable 
comparison with other studies, although we acknowledge 
its limitation on sample size.
This study aimed to evaluate the relationship between 
grip strength and lung function in older persons and whether 
current guidelines may inadvertently lead to clinicians 
misdiagnosing and potentially treating older nonsmokers 
with unnecessary and potentially harmful treatment. 
A larger community-based study using the same rigorous 
methodology may provide a better understanding of this 
relationship.
It could be that a larger number of older persons in the 
community would benefit from this research due to the 
increasing screening programs in primary care. It may also 
be easier to perform grip strength and spirometry within an 
outpatient setting in a more consistent fashion. It has also 
been demonstrated in older adults that fixed ratio FEV
1
/FVC 
may better identify subjects at risk of death or hospitalization 
than using the lower limit of normal spirometry values.32 
Hence, this area of debate may be more complicated than 
simply disease classification.
Future work may consider review of grip strength to lung 
function expressed in terms of the diagnostic cutoff values 
for COPD using both the lower limit of normal and the fixed 
ratio criteria.
There may be other avenues of assessing the relationship 
between grip strength and spirometry in older nonsmokers 
using additional biochemical markers for aging and measur-
ing FEV at the earlier part of forced expiration to increase 
accuracy of results before fatigability sets in.
Pulmonary rehabilitation programs are established for 
patients with COPD. Similarly resistance training has been 
recognized as important in maintaining muscle mass and 
strength in older people. There may be the potential for pul-
monary rehabilitation programs for older people in the future 
to maintain respiratory muscle mass and strength.32
Conclusion
Men had significantly stronger grip strength and larger FEV
1
, 
FVC, PEFR, and SVC compared with women probably 
because of larger body size. There was a significant associa-
tion between grip strength and PEFR and grip strength and 
SVC after adjustment for age, height, and weight in women, 
which may reflect stronger patients generating higher intra-
thoracic pressure at the start of spirometry and pushing harder 
against thoracic cage recoil at end-expiration. In men, a 
significant relationship was found between grip strength and 
FEV
1
, which was attenuated after adjustment for age, height, 
and weight, and this requires further evaluation.
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